HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vijaya Ramesh Selected Research

Phosphatidylinositols (Phosphatidylinositol)

8/2009NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vijaya Ramesh Research Topics

Disease

25Neoplasms (Cancer)
01/2024 - 11/2002
16Tuberous Sclerosis (Bourneville's Disease)
10/2023 - 11/2003
15Meningioma (Meningiomas)
01/2024 - 02/2008
9Neurofibromatosis 2 (Neurofibromatosis Type II)
06/2024 - 11/2004
8Neurilemmoma (Schwannoma)
06/2024 - 08/2009
4Autism Spectrum Disorder
10/2023 - 03/2013
3Neurofibromatoses (Neurofibromatosis)
01/2019 - 02/2010
2Neurocutaneous Syndromes (Phakomatoses)
10/2023 - 03/2023
2Intellectual Disability (Idiocy)
10/2023 - 01/2020
2Carcinogenesis
01/2018 - 02/2008
2Schwannomatosis
06/2017 - 03/2014
2Chordoma
03/2009 - 09/2004
2Hamartoma
09/2004 - 11/2003
2Dystonia (Limb Dystonia)
05/2004 - 02/2003
1Leukemia
01/2021
1Tauopathies
01/2021
1Frontotemporal Dementia (Semantic Dementia)
01/2021
1Acoustic Neuroma (Acoustic Neurinoma)
01/2020
1Epilepsy (Aura)
01/2020
1Neurodevelopmental Disorders
01/2020
1Sarcoma (Soft Tissue Sarcoma)
06/2017
1Glioma (Gliomas)
06/2017
1Neuroblastoma
06/2017
1Weight Gain
10/2015
1Autistic Disorder (Autism)
03/2013
1Movement Disorders (Movement Disorder)
05/2004
1Dystonia musculorum deformans type 1
02/2003
1Inflammation (Inflammations)
02/2003
1Neurologic Manifestations (Neurological Manifestations)
11/2002

Drug/Important Bio-Agent (IBA)

13trans-sodium crocetinate (crocetin)IBA
10/2023 - 11/2003
12Neurofibromin 2 (Merlin)IBA
09/2022 - 11/2004
11Sirolimus (Rapamycin)FDA Link
01/2024 - 08/2008
11Proteins (Proteins, Gene)FDA Link
07/2015 - 02/2003
10Mechanistic Target of Rapamycin Complex 1IBA
01/2024 - 03/2009
6Tuberous Sclerosis Complex 2 ProteinIBA
01/2021 - 11/2002
5Phosphotransferases (Kinase)IBA
01/2021 - 05/2012
4Mechanistic Target of Rapamycin Complex 2IBA
01/2023 - 05/2012
4Tuberous Sclerosis Complex 1 ProteinIBA
01/2021 - 11/2002
4TOR Serine-Threonine KinasesIBA
01/2018 - 06/2008
3vistusertibIBA
01/2023 - 07/2015
3Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
07/2015 - 11/2004
2MTOR InhibitorsIBA
01/2024 - 07/2015
2Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2017
2EphA1 Receptor (Eph Receptor)IBA
01/2020 - 01/2018
2Dasatinib (BMS 354825)FDA Link
01/2020 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 02/2003
2Mediator ComplexIBA
01/2015 - 11/2007
2radixinIBA
08/2005 - 11/2004
1sapanisertibIBA
01/2024
1RNA (Ribonucleic Acid)IBA
01/2023
1Cytostatic AgentsIBA
01/2023
1Annexin A5IBA
01/2023
1ChromatinIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1tau Proteins (tau Protein)IBA
01/2021
1brigatinibIBA
01/2021
1LigandsIBA
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1NeuregulinsIBA
01/2021
1Neuregulin-1 (Neuregulin 1)IBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2020
1Therapeutic UsesIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1Drug CombinationsIBA
01/2018
1PanobinostatIBA
01/2018
1omipalisibIBA
01/2018
1Uvitex SWN (SWN)IBA
06/2017
1VimentinIBA
01/2016
1serum-glucocorticoid regulated kinaseIBA
07/2015
1FRAX597IBA
07/2015
1ElementsIBA
02/2011
1Phosphatidylinositols (Phosphatidylinositol)IBA
08/2009
1TensinsIBA
03/2009
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
03/2009
1ezrinIBA
11/2004
1moesinIBA
11/2004
1KinesinsIBA
05/2004
1Glutamic Acid (Glutamate)FDA Link
05/2004
1Mitogen-Activated Protein KinasesIBA
02/2004

Therapy/Procedure

14Therapeutics
06/2024 - 05/2012
5Drug Therapy (Chemotherapy)
01/2024 - 02/2010
1Aftercare (After-Treatment)
01/2018